iShares U.S. Pharmaceuticals ETF (IHE) Chart & Stock Price History $70.67 +0.63 (+0.90%) As of 03:22 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Pharmaceuticals ETF Stock Price Performance The iShares U.S. Pharmaceuticals ETF (IHE) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 1.74%, with a year-to-date return of 7.53%. In the past month, the fund has increased 2.02%, reflecting recent market activity. As of the latest close, iShares U.S. Pharmaceuticals ETF traded at $70.04 with a market cap of $574.33 million and volume of 20,567 shares. Five years ago, the fund traded at a split-adjusted price of $55.14, representing a 28.16% increase over that period. At the time, it had a market cap of $351.26 million and a volume of 26,583 shares. Receive IHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.18%1 Month Performance+2.02%3 Month Performance+11.12%Year-To-Date Performance+7.53%1 Year Performance-1.74%5 Year Performance+28.16% IHE Stock Chart for Tuesday, August, 26, 2025 IHE Chart by TradingView iShares U.S. Pharmaceuticals ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025$70.99$70.04-1.34%$71.01$70.0120,567 shs$574.33 million08/22/2025$70.54$70.99+0.64%$71.40$70.8154,779 shs$582.12 million08/21/2025$70.19$70.54+0.50%$70.88$69.8059,164 shs$578.43 million08/20/2025$69.83$70.19+0.52%$70.24$69.7620,800 shs$575.56 million08/19/2025$69.50$69.83+0.47%$70.19$69.6524,908 shs$572.61 million08/18/2025$69.67$69.50-0.24%$70.07$69.4928,258 shs$569.90 million08/15/2025$69.10$69.67+0.82%$69.94$69.1222,762 shs$571.29 million08/14/2025$68.43$69.10+0.98%$69.11$67.9117,977 shs$566.62 million08/13/2025$67.00$68.43+2.13%$68.50$67.1527,060 shs$561.13 million08/12/2025$66.38$67.00+0.93%$67.00$66.5057,957 shs$549.40 million Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 08/11/2025$66.06$66.38+0.48%$66.93$66.2325,665 shs$552.64 million08/08/2025$65.74$66.06+0.49%$66.23$65.6042,503 shs$541.69 million08/07/2025$66.77$65.74-1.54%$66.10$64.9473,323 shs$539.07 million08/06/2025$67.73$66.77-1.42%$67.16$66.6220,835 shs$547.51 million08/05/2025$67.94$67.73-0.31%$67.98$67.3846,729 shs$555.39 million08/04/2025$66.79$67.94+1.72%$67.94$66.5620,320 shs$557.11 million08/01/2025$65.75$66.79+1.58%$66.89$65.6341,614 shs$547.68 million07/31/2025$67.29$65.75-2.29%$67.22$65.5439,280 shs$539.15 million07/30/2025$67.70$67.29-0.61%$68.21$67.1053,735 shs$551.78 million07/29/2025$68.65$67.70-1.38%$68.04$67.6058,483 shs$555.14 million07/28/2025$69.27$68.65-0.90%$69.22$68.3224,601 shs$562.93 million07/25/2025$69.25$69.27+0.03%$69.46$68.6916,251 shs$568.01 million Related Companies PPH Stock Chart LABU Stock Chart RSPH Stock Chart IHF Stock Chart BBH Stock Chart PJP Stock Chart FXH Stock Chart PBE Stock Chart CURE Stock Chart XPH Stock Chart Receive IHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:IHE) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access